40 related articles for article (PubMed ID: 9041753)
1. Advancing Reliable Data for Cancer Control in the Central America Four Region.
Piñeros M; Frech S; Frazier L; Laversanne M; Barnoya J; Garrido C; Gharzouzi E; Chacón A; Fuentes Alabi S; Ruiz de Campos L; Figueroa J; Dominguez R; Rojas O; Pereira R; Rivera C; Morgan DR
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241165
[TBL] [Abstract][Full Text] [Related]
2. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.
Sagae S; Monk BJ; Pujade-Lauraine E; Gaffney DK; Narayan K; Ryu SY; McCormack M; Plante M; Casado A; Reuss A; Chávez-Blanco A; Kitchener H; Nam BH; Jhingran A; Temkin S; Mileshkin L; Berns E; Scholl S; Doll C; Abu-Rustum NR; Lecuru F; Small W;
Int J Gynecol Cancer; 2016 Jan; 26(1):199-207. PubMed ID: 26569057
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer control in developing countries: memorandum from a WHO meeting.
Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
[TBL] [Abstract][Full Text] [Related]
7. Workshop on screening for cancer of the uterine cervix in Central America.
Miller AB; Robles SC
Bull Pan Am Health Organ; 1996 Dec; 30(4):397-408. PubMed ID: 9041753
[TBL] [Abstract][Full Text] [Related]
8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix.
Parboosingh EJ; Anderson G; Clarke EA; Inhaber S; Kaegi E; Mills C; Mao Y; Root L; Stuart G; Stachenko S
CMAJ; 1996 Jun; 154(12):1847-53. PubMed ID: 8653644
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development.
Lazcano-Ponce E; Alonso P; Ruiz-Moreno JA; Hernández-Avila M
Salud Publica Mex; 2003; 45 Suppl 3():S449-62. PubMed ID: 14746039
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
